Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…al bone damage over 48 months in patients with PsA treated with secukinumab, suggesting that anti-IL-17A therapy induces sustained osteopro…
…30; P=0.172), or poor prognosis (RR, 0.981; P=0.896).Conclusion Tirofiban effectively lowers the risk of thrombosis without increasing bl…
…ombectomy (MT) for distal medium vessel occlusions (DMVOs). The RED 43 catheter has been introduced as a primary catheter for distal aspiration…
…enchymal transition (EMT) in MAILD are incompletely understood. Anlotinib, a multitarget tyrosine kinase inhibitor, shows potential in fi…
…Introduction Prescription digital therapeutics (PDTx) represent an emerging frontier in healthcare, leveraging softw…
… raised to NHS England’s National Patient Safety Team regarding tranexamic acid use in gastrointestinal bleeding, and in light of the 2020 publ…
… in lifetime costs due to earlier diagnosis (€)Cost savings per HbA1c level1-year earlier diagnosis3-year earlier diagnosis5-year ear…
…ive To evaluate the feasibility and acceptability of daily oral emtricitabine/tenofovir alafenamide fumarate (FTC/TAF) as HIV pre-exposure prophylaxis (PrEP) among people w…
…-mediated mechanism, most likely as an immune-related effect of ipilimumab and nivolumab.…
…the leading causes of maternal mortality. A single oral dose of azithromycin (AZM; 2 g) is safe and effectively reduces 33%–60% of maternal …
…Introduction Norepinephrine (NE) and phenylephrine (PE) are routinely administered vasopres…
…). Bleeding complications occurred in one (0.6%) patient in the heparin-free group, three (1.9%) patients in the heparinisation group and ni…